BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29391013)

  • 1. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
    Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
    Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
    EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
    Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
    Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
    Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
    Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes alters the association between high-density lipoprotein subfractions and carotid intima-media thickness: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Generoso G; Bensenor IM; Santos IS; Santos RD; Goulart AC; Jones SR; Kulkarni KR; Blaha MJ; Toth PP; Lotufo PA; Bittencourt MS
    Diab Vasc Dis Res; 2018 Nov; 15(6):541-547. PubMed ID: 30024274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein cholesterol subfractions in older people.
    Ettinger WH; Verdery RB; Wahl PW; Fried LP
    J Gerontol; 1994 May; 49(3):M116-22. PubMed ID: 8169333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary plaque burden and composition on periprocedural myocardial infarction and coronary flow reserve after percutaneous coronary intervention.
    Higuchi Y; Hiro T; Takayama T; Kanai T; Kawano T; Fukamachi D; Sudo M; Nishida T; Iida K; Saito S; Hirayama A
    Int Heart J; 2014; 55(5):391-6. PubMed ID: 25070121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density Lipoprotein-cholesterol Subfractions and Coronary Artery Calcium: The ELSA-Brasil Study.
    Generoso G; Bensenor IM; Santos RD; Staniak HL; Sharovsky R; Santos IS; Goulart AC; Jones SR; Kulkarni KR; Blaha MJ; Toth PP; Lotufo PA; Bittencourt MS
    Arch Med Res; 2019 Aug; 50(6):362-367. PubMed ID: 31678894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
    J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention.
    Hosoda H; Asaumi Y; Noguchi T; Morita Y; Kataoka Y; Otsuka F; Nakao K; Fujino M; Nagai T; Nakai M; Nishimura K; Kono A; Komori Y; Hoshi T; Sato A; Kawasaki T; Izumi C; Kusano K; Fukuda T; Yasuda S
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):5. PubMed ID: 31941517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
    Deng Q; Hou J; Deng X; Zhong Z
    Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.